Published in Atherosclerosis on January 21, 1972
Analysis of genetic and environmental sources of variation in serum cholesterol in Tecumseh, Michigan. III. Identification of genetic effects using 12 polymorphic genetic blood marker systems. Am J Hum Genet (1976) 1.42
Blood groups, serum cholesterol, serum uric acid, blood pressure, and obesity in adolescents. J Natl Med Assoc (1991) 0.75
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Illuminating the 'black box'. A description of 4454 patient visits to 138 family physicians. J Fam Pract (1998) 4.70
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA (1998) 3.37
Additional specificities of Australia antigen and the possible identification of hepatitis carriers. Nature (1969) 2.28
In-hospital and 1-year mortality in 1,524 women after myocardial infarction. Comparison with 4,315 men. Circulation (1991) 2.13
Long-term mortality follow-up of hospital survivors of a myocardial infarction randomized to nifedipine in the SPRINT study. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Cardiovasc Drugs Ther (1998) 2.01
Self-reported physical activity predicts long-term coronary heart disease and all-cause mortalities. Twenty-one-year follow-up of the Israeli Ischemic Heart Disease Study. Arch Fam Med (1995) 1.96
Characteristics of smokers, non-smokers and ex-smokers among 10,000 adult males inIsrael. II. Physiologic, biochemical and genetic characteristics. Am J Epidemiol (1977) 1.78
Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men. Arterioscler Thromb Vasc Biol (1997) 1.76
High density lipoprotein cholesterol and incidence of coronary heart disease--the Israeli Ischemic Heart Disease Study. Am J Epidemiol (1979) 1.75
Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology (2004) 1.70
Major factors in the development of diabetes mellitus in 10,000 men. Arch Intern Med (1975) 1.62
Long-term prognosis of women after myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Am J Epidemiol (1997) 1.62
Factors predictive of long-term coronary heart disease mortality among 10,059 male Israeli civil servants and municipal employees. A 23-year mortality follow-up in the Israeli Ischemic Heart Disease Study. Cardiology (1993) 1.60
Does diuretic therapy increase the risk of renal cell carcinoma? Am J Cardiol (1999) 1.60
The periodic health examination of older adults: the recommendations of the U.S. Preventive Services Task Force. Part II. Screening tests. J Am Geriatr Soc (1990) 1.58
Angina pectoris among 10,000 men. II. Psychosocial and other risk factors as evidenced by a multivariate analysis of a five year incidence study. Am J Med (1976) 1.58
Voluntary and involuntary weight loss: associations with long term mortality in 9,228 middle-aged and elderly men. Am J Epidemiol (1998) 1.56
Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-up. Cardiology (1999) 1.52
Total and high density lipoprotein cholesterol in the serum and risk of mortality: evidence of a threshold effect. Br Med J (Clin Res Ed) (1985) 1.44
Mortality trends in men and women with acute myocardial infarction in coronary care units in Israel. A comparison between 1981-1983 and 1992-1994. For the SPRINT and the Israeli Thrombolytic Survey Groups. Eur Heart J (2000) 1.43
Health and function in the old and very old. J Am Geriatr Soc (1988) 1.43
Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease. J Am Coll Cardiol (1999) 1.42
Risk factors and segment-specific carotid arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke (1996) 1.41
Primary ventricular tachycardia in acute myocardial infarction: clinical characteristics and mortality. The SPRINT Study Group. Ann Intern Med (1992) 1.41
The periodic health examination of older adults: the recommendations of the U.S. Preventive Services Task Force. Part I. Counseling, immunizations, and chemoprophylaxis. J Am Geriatr Soc (1990) 1.41
Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group. J Am Coll Cardiol (1998) 1.40
Calcium antagonists and mortality in patients with coronary artery disease: a cohort study of 11,575 patients. J Am Coll Cardiol (1996) 1.40
Donors with a rare pheno (geno) type. Vox Sang (2008) 1.35
An epidemiologic investigation of hypertension and ischemic heart disease within a defined segment of the adult male population of Israel. Isr J Med Sci (1968) 1.30
Diabetes, prediabetes and uricaemia. Diabetologia (1976) 1.29
Factors related to diabetes incidence: a multivariate analysis of two years observation on 10,000 men. The Israel Ischemic Heart Disease Study. J Chronic Dis (1971) 1.28
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27
Uric acid and diabetes: observations in a population study. Lancet (1982) 1.24
Five-year myocardial infarction incidence. II. Association of single variables to age and birthplace. J Chronic Dis (1973) 1.22
Blood groups, myocardial infarction and angina pectoris among 10,000 adult males. N Engl J Med (1971) 1.22
The family life cycle and its implications for family practice. J Fam Pract (1979) 1.21
Family determinants of disease. I. General principles and concepts. Fam Pract (1984) 1.18
International Society of Blood Transfusion Committee on terminology for red blood cell surface antigens: Macao report. Vox Sang (2009) 1.17
International Society of Blood Transfusion Committee on terminology for red cell surface antigens: Vancouver Report. Vox Sang (2003) 1.16
Patient perceptions of humanism in physicians: effects on positive health behaviors. Fam Med (1991) 1.16
Genetic aspects of arteriosclerosis. Arteriosclerosis (1986) 1.16
Comprehensive follow-up of carcinoma patients. J Chronic Dis (1971) 1.15
Unrecognized myocardial infarction: five-year incidence, mortality, and risk factors. Ann Intern Med (1976) 1.13
Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: the Bezafibrate Infarction Prevention (BIP) Registry. Circulation (1999) 1.13
The epidemiology of coronary heart disease in the ethnically and culturally diverse population of Israel. A review. Isr J Med Sci (1982) 1.13
High-density lipoprotein cholesterol and risk of ischemic stroke mortality. A 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study. Stroke (1997) 1.12
Weight-height indices. Choice of the most suitable index and its association with selected variables among 10,000 adult males of heterogeneous origin. Br J Prev Soc Med (1974) 1.12
Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction. SPRINT Study Group. Eur Heart J (1992) 1.11
Blood group terminology 2004: from the International Society of Blood Transfusion committee on terminology for red cell surface antigens. Vox Sang (2004) 1.11
Diabetes mellitus among 10,000 adult men. I. Five-year incidence and associated variables. Isr J Med Sci (1974) 1.11
The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. J Clin Epidemiol (1995) 1.08
Histocompatibility determinants in Israeli Jewish patients with coeliac disease: population and family study. Tissue Antigens (1981) 1.08
The incidence of hypertension and associated factors: the Israel ischemic heart disease study. Am Heart J (1972) 1.06
Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) Registry: high triglycerides constitute an independent risk factor. Circulation (2001) 1.05
Random repeat 24-hour dietary recalls. Am J Clin Nutr (1971) 1.04
Antihypertensive therapy and the risk of malignancies. Eur Heart J (2001) 1.04
Circadian variation and possible external triggers of onset of myocardial infarction. SPRINT Study Group. Am J Med (1993) 1.04
Malignant arrhythmias in relation to values of serum potassium in patients with acute myocardial infarction. Int J Cardiol (1991) 1.04
Characteristics of smokers, nonsmokers and ex-smokers among 10,000 adult males in Israel. I. Distribution of selected sociodemographic and behavioral variables and the prevalence of disease. Isr J Med Sci (1975) 1.03
Ten-year survival after acute myocardial infarction: comparison of patients with and without diabetes. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Am Heart J (1997) 1.03
Prevalence and prognosis of chronic obstructive pulmonary disease among 5,839 consecutive patients with acute myocardial infarction. SPRINT Study Group. Am J Med (1992) 1.02
A "new" phenotype confirming a relationship between Cra and Tca. Transfusion (1984) 1.01
Congenital dislocation of the hip--a clinical-epidemiological study, Jerusalem 1954 to 1960. I. Retrospective incidence study. Isr J Med Sci (1966) 1.01
The frequency of sexual problems among family practice patients. Fam Pract Res J (1988) 1.01
Prevalence and 15-year incidence of retinopathy and associated characteristics in middle-aged and elderly diabetic men. Br J Ophthalmol (1983) 0.99
Myocardial infarction over a five-year period. I. Prevalence, incidence and mortality experience. J Chronic Dis (1973) 0.99
Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. SPRINT Study Group. Am J Med (1993) 0.99